CPRX — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

8.84

Margin Of Safety %

Put/Call OI Ratio

0.83

EPS Next Q Diff

0.27

EPS Last/This Y

1.1

EPS This/Next Y

0.26

Price

Target Price

Analyst Recom

1.14

Performance Q

9.61

Upside

135.3%

Beta

0.69

Ticker: CPRX

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-09	CPRX	24.8	0.61	0.22	9905
2026-03-10	CPRX	24.76	0.61	0.06	9922
2026-03-11	CPRX	24.4	0.56	3.28	10511
2026-03-12	CPRX	23.39	0.57	0.55	10603
2026-03-13	CPRX	23.39	0.57	0.56	10603
2026-03-17	CPRX	23.31	0.59	0.24	10964
2026-03-18	CPRX	22.8	0.58	0.20	11051
2026-03-19	CPRX	22.34	0.54	0.14	11454
2026-03-20	CPRX	22.79	0.55	0.04	11230
2026-03-23	CPRX	23.32	0.77	0.16	6161
2026-03-24	CPRX	23.06	0.74	22.04	6489
2026-03-25	CPRX	23.79	0.87	2.79	7008
2026-03-26	CPRX	24.25	0.87	1.18	7088
2026-03-27	CPRX	23.4	0.89	0.12	7556
2026-03-30	CPRX	23.77	0.89	0.00	7560
2026-03-31	CPRX	24.78	0.88	0.01	7608
2026-04-01	CPRX	24.83	0.86	0.04	7707
2026-04-02	CPRX	24.69	0.80	1.08	8035
2026-04-06	CPRX	24.98	0.83	0.36	8299
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-09	CPRX	24.79	-6.6	31.0	2.85
2026-03-10	CPRX	24.76	-6.6	22.0	2.85
2026-03-11	CPRX	24.40	-6.6	17.0	2.85
2026-03-12	CPRX	23.40	-6.6	7.3	2.85
2026-03-13	CPRX	23.22	-6.6	19.4	2.85
2026-03-17	CPRX	23.33	-6.6	22.8	2.85
2026-03-18	CPRX	22.80	-6.6	14.0	2.85
2026-03-19	CPRX	22.33	-6.6	14.5	2.85
2026-03-20	CPRX	22.78	-6.6	30.2	2.85
2026-03-23	CPRX	23.32	-6.6	31.1	2.85
2026-03-24	CPRX	23.06	-6.6	18.2	2.85
2026-03-25	CPRX	23.80	-6.6	34.4	2.85
2026-03-26	CPRX	24.25	-6.6	29.3	2.85
2026-03-27	CPRX	23.41	-6.6	9.6	2.85
2026-03-30	CPRX	23.76	-6.6	28.1	2.85
2026-03-31	CPRX	24.77	-6.6	37.9	2.85
2026-04-01	CPRX	24.83	-6.6	23.1	2.85
2026-04-02	CPRX	24.69	-6.6	20.4	2.85
2026-04-06	CPRX	24.99	-6.6	26.7	2.85
2026-04-07	CPRX	25.00	-6.6	22.4	2.85
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-09	CPRX	-0.54	1.16	8.74
2026-03-10	CPRX	-0.54	1.16	8.74
2026-03-11	CPRX	-0.30	1.16	8.46
2026-03-12	CPRX	-0.30	1.16	8.46
2026-03-13	CPRX	-0.30	1.16	8.46
2026-03-17	CPRX	-0.30	1.19	8.46
2026-03-18	CPRX	-0.30	1.19	8.46
2026-03-19	CPRX	-0.30	1.19	8.46
2026-03-20	CPRX	-0.30	1.19	8.46
2026-03-23	CPRX	-0.30	1.19	8.46
2026-03-24	CPRX	-0.30	1.19	8.46
2026-03-25	CPRX	-0.30	1.19	8.84
2026-03-26	CPRX	-0.30	1.19	8.84
2026-03-27	CPRX	-0.30	1.19	8.84
2026-03-30	CPRX	-0.30	1.17	8.84
2026-03-31	CPRX	-0.30	1.17	8.84
2026-04-01	CPRX	-0.30	1.17	8.84
2026-04-02	CPRX	-0.30	1.17	8.84
2026-04-06	CPRX	-0.30	1.34	8.84
2026-04-07	CPRX	-0.30	1.34	8.84
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

0.4

Avg. EPS Est. Current Quarter

0.64

Avg. EPS Est. Next Quarter

0.67

Insider Transactions

-0.3

Institutional Transactions

1.34

Beta

0.69

Average Sales Estimate Current Quarter

147

Average Sales Estimate Next Quarter

151

Fair Value

29.15

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

5.9

Max Drawdown 5-Year %

-45.4

Target Price

P/E

14.84

Forward P/E

11.6

PEG

1.16

P/S

5.18

P/B

3.21

P/Free Cash Flow

14.63

EPS

1.68

Average EPS Est. Cur. Y

2.85

EPS Next Y. (Est.)

3.12

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

36.39

Relative Volume

0.98

Return on Equity vs Sector %

-5

Return on Equity vs Industry %

11.5

EPS 1 7Days Diff

0.3

EPS 1 30Days Diff

0.26

EBIT Estimation

22.4

◆ CPRX Healthcare

$24.99

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

12/20

Pullback

10/25

Volume

4/15

Valuation

15/20

TP/AR

2/10

Options

0/10

RSI

59.2

Range 1M

86.5%

Sup Dist

1.2%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

8/25

Growth

13/30

Estimates

6/20

Inst/Vol

6/15

Options

0/10

EPS Yr

10%

EPS NY

16.6%

52W%

78.9%

💎

Long-Term Value

Quality companies, undervalued

WATCH

🟢 BUY +180.7% upside

Quality

25/30

Valuation

23/30

Growth

10/25

Stability

8/10

LT Trend

3/5

Upside

+180.7%

Quality

MoS

17%

Catalyst Pharmaceuticals, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 182

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States. It offers Firdapse for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); Fycompa, a novel non-competitive selective antagonist at the postsynaptic ionotropic alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid glutamate receptor that is used to treat focal onset seizures, as well as tonic-clonic seizure; and AGAMREE, a corticosteroid for the treatment of duchenne muscular dystrophy. The company has license agreements with BioMarin Pharmaceutical Inc.; and a collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida.

CPRX

Latest News

—

Caricamento notizie per CPRX…

stock quote shares CPRX – Catalyst Pharmaceuticals, Inc. Stock Price stock today

news today CPRX – Catalyst Pharmaceuticals, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch CPRX – Catalyst Pharmaceuticals, Inc. yahoo finance google finance

stock history CPRX – Catalyst Pharmaceuticals, Inc. invest stock market

stock prices CPRX premarket after hours

ticker CPRX fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: CPRX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y